IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway (Q39030466)

8 September 2017

IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway (English)

1 reference

8 September 2017

1 reference

Le Zhang

1

1 reference

8 September 2017

Jun Li

2

1 reference

8 September 2017

Li Li

3

1 reference

8 September 2017

Jie Zhang

4

1 reference

8 September 2017

Xiaodong Wang

5

1 reference

8 September 2017

Chuanhua Yang

6

1 reference

8 September 2017

Yanyan Li

7

1 reference

8 September 2017

Feng Lan

8

1 reference

8 September 2017

Ping Lin

9

1 reference

8 September 2017

language of work or name

English

0 references

publication date

24 January 2014

1 reference

8 September 2017

1 reference

8 September 2017

35

1 reference

8 September 2017

6

1 reference

8 September 2017

1330-1340

1 reference

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

8 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Worldwide variations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

A unique role for IL-23 in promoting cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

IL-23 in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

Suppressor of cytokine signalling (SOCS) 1 and 3 enhance cell adhesion and inhibit migration towards the chemokine eotaxin/CCL11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU017

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGU017

1 reference

8 September 2017

1 reference